Vascular Biology |
From Service de Cardiologie Pédiatrique (Y.A., D.B., D.S.), Hôpital Necker Enfants Malades; Service de Physiologie Explorations Fonctionnelles AP-HP and Unit 541 INSERM (B.I.L.), Hôpital Lariboisière; Service de Médecine I (M.E.S.), Hôpital Broussais; Service de Gastroentérologie et Nutrition Pédiatrique (J.P.G.), Hôpital dEnfants A. Trousseau; Service dEndocrinologie Pédiatrique (M.P.), Hopital Robert Debré; and Service dEndocrinologie-Métabolisme (E.B.), Groupe Hospitalier Pitié-Salpétrière, Paris, France.
Correspondence to Pr Bernard Levy, INSERM U541, 41 Bd de la Chapelle 75475, Paris Cedex 10, France. E-mail levy{at}infobiogen.fr
| Abstract |
|---|
|
|
|---|
Key Words: endothelium flow-dependent dilation arterial compliance
| Introduction |
|---|
|
|
|---|
In the early stage of hypercholesterolemia, endothelium function is modified and represents an early event in the natural history of vascular disease, in particular with impairment in endothelium-dependent relaxation, which has been recognized as an early abnormality.2 3 4 Indeed, nitric oxide (NO) is released by an increase in shear stress on the endothelial cell luminal surface as flow rises. Abnormalities in the reactivity of arteries, consisting of potential constriction and impaired relaxation, have been reported with hypercholesterolemia even in the absence of visible atherosclerotic lesions.5 6 7 In young patients (10 to 19 years old) with familial hypercholesterolemia (FH), the classic lipid and hemostatic risk factors as well as plasma total homocysteine are associated with echographic markers of early carotid atherosclerosis.8 We hypothesized that stiffening of large arteries could be an early marker of atherosclerosis, preceding IMT and the appearance of echographic plaques.
Therefore, the aim of the present study was to evaluate, by using an automatic, computerized, ultrasonic procedure, the geometric and mechanical properties of large arterial vessels in young children with FH. We chose the common carotid artery (CCA) because this vessel, which is close to the heart and rich in elastic fibers, is a representative site that enables evaluation of the "buffering" function of central arteries and contributes to the early stages of large-artery stiffening.9 10 11
| Methods |
|---|
|
|
|---|
Subjects with primary FH (mean±SD age, 11.1±2.0 years) were normotensive (systolic/diastolic blood pressure, 109±9/55±7 mm Hg), nonobese (40±6 kg), and nondiabetic and had no clinical evidence of cardiovascular, neurological, or renal diseases. The FH patients had class IIA hypercholesterolemia (Friedericksons criteria). Diagnostic criteria for FH were (1) increased LDL cholesterol levels (>1.9 g/L), (2) eventual presence of xanthomas, and (3) a family history of hypercholesterolemia. Children with familial combined hyperlipoproteinemia, hypertriglyceridemia, familial chylomicronemia, dysbetalipoproteinemia, and secondary hyperlipoproteinemias were excluded from the present study.
All FH patients (n=30) received dietary treatment, and 10 had taken cholesterol-lowering drugs for elevated LDL cholesterol levels, 5 took a bile acid sequestrant in doses of 4 to 8 g (cholestyramine), 4 were being treated with fenofibrate (lipanthyl), and 1 patient received both cholysteramine and fenofibrate. The mean duration of treatment was 24±11 months (range, 6 to 36 months).
Laboratory Analysis
Plasma lipids were measured in venous blood samples
obtained after an overnight fast. Serum total cholesterol
and triglyceride values were measured by classic enzymatic
methods. HDL cholesterol was measured by enzymatic methods
after selective precipitation of LDL and VLDL by the phosphotungstic
acid method.12 13 LDL cholesterol was
calculated according to the classic formula of Friedewald et
al14 : LDL cholesterol=total
cholesterol-HDL
cholesterol-(triglycerides/5).
Protocol and Data Analysis
Examination of the subjects was performed at a controlled room
temperature of 22±1°C. Blood pressure and heart rate were measured,
after the subjects had been lying supine for 10 minutes, automatically
by an oscillometric recorder (Dynamap model 8100, Critikon) on the
left arm. Brachial systolic and diastolic blood
pressures were used as an estimate of the carotid pressure at the
moment of the echographic examination.
CCA Measurements
IMT Measurement
Noninvasive measurements were performed with a real-time, B-mode
ultrasound imager (Acuson XP 128). The right CCA was examined with a
7-MHz vascular probe as previously described.15 16 The IMT
and lumen diameter measurements were performed in all subjects 1 to 2
cm proximal to the carotid bifurcation and along at least 1 cm of axial
length. The same physician performed all measurements throughout the
study (Y.A.). During scanning, the operator adjusted the sound beam
perpendicular to the far wall of the vessel, thereby obtaining 2
parallel echogenic lines corresponding to the lumen intima-media and
media-adventitia interfaces. The gain setting was adjusted to visualize
2D images for proximal and distal carotid walls: for each wall, 2
parallel line echoes were separated by a small, echo-free space. The
IMT was measured between the 2 leading edges corresponding to the far
wall of the CCA. Once these 2 parallel echogenic lines were clearly
visible along at least 1.5 cm of the measured segment, the "frozen"
end-diastolic (electrocardiographic R triggering) vessel
image was transferred to a computer (Apple Macintosh 7100/80). Offline
image analysis was then performed with an appropriate program
(Iotec, IôDP System). This program is based on the
analysis of gray-level densities and on specific
tissue-recognition algorithms; it was used after a 3.63-fold
magnification of the anatomic structure was examined. At first, the
observer chose a region of interest that specifically included the
far-wall IMT and drew a rectangle at least 1.5 cm long in the
longitudinal axis of the vessel and at least 0.3 cm thick perpendicular
to the wall. The computer located the 2 interfaces (lumen-intima and
media-adventitia) by discriminating changes in gray levels inside the
sample area and drew the 2 parallel lines representing
these interfaces on the computer monitor. The average IMT obtained from
the sample area represented the mean of at least 100
successive measurements of the distance between the 2 interfaces along
1.5 cm of artery.
Determination of Systolic and Diastolic CCA
Lumen Diameters
The sequence of B-mode images (50 frames/s) was stored by the
computer for at least 5 cardiac cycles and then analyzed frame
by frame (Iotec, IôDP). As for the IMT measurement, the proximal
and distal walls were detected automatically by analyzing the mean
gray-level profile of the frames. The relative displacement between
gray-level profiles corresponding to consecutive frames was then
measured. The diameter variations over at least 5 cardiac cycles as
well as the synchronized electrocardiogram were
visualized on the computer screen for visual agreement. The
diastolic diameter was calculated as the mean of the
minimal values of CCA lumen, corresponding to the R wave, for 5
consecutive cardiac cycles. In the same way, the systolic
diameter was estimated as the mean of the maximal value of CCA lumen
during the same cardiac cycles.
The following mechanical property parameters of the right
CCA were measured or computed from echographic and pressure
measurements: lumen diastolic diameter (dD),
lumen systolic diameter (sD), absolute stroke change
in diameter (
D=sD -dD), relative
stroke change in diameter (sD -dD/dD)
or strain (
), and end-diastolic IMT. The wall
cross-sectional area (WCSA) was calculated as
(Re2
-Ri2), where Re is the
diastolic internal radius (Ri) plus IMT.
WCSA is not influenced by blood pressure because of the
incompressibility of the arterial
mass,17 which remains constant during the
whole cardiac cycle.
The relation between pressure changes (
P) and volume
changes (
V) defines the compliance,
C=
V/
P. The cross-sectional
compliance (CSC) was calculated from the formula
CSC=
xdD(sD-
dD)/2PP (mm2
· mm Hg-1), and the cross-sectional
distensibility (CSD) was calculated from the pulsatile
changes in diameters and pulsatile changes in pressure by using the
formula CSD=2x(sD-
dD)/(PPxdD)
(mm Hg-1), where PP is pulse
pressure.10 11 18 The incremental elastic modulus
(Einc, mm Hg), defined by the
stiffness of the carotid wall, was estimated by the formula
Einc=3/CSD[1-(1-
)2],
where
is the IMT/(Dd/2) ratio.19 Wall
stress was calculated as the diastolic arterial
pressure divided by
(mm Hg).
Repeatability of Measurements
The examinations and all measurements (IMT and diameters) were
performed by the same investigator in a blinded fashion, ie, without
any information about the status of the subject (control or FH) during
data acquisition and treatment. Series of paired measurements were
compared and analyzed according to the recommendation of Bland
and Altman.20 Repeatability of IMT and of
diastolic and systolic diameters was investigated
in 10 different subjects through calculation of a repeatability
coefficient (RC),21 where
(RC)2=
Di2/n,
where n is the sample size and Di is the
difference between 2 measurements in a pair. This coefficient is the SD
of the estimated difference between 2 repeated measurements. The
RC values for intraobserver repeatability (comparison of 2
determinations separated by a 2-hour interval and obtained by the same
observer) concerning IMT and diastolic and systolic
diameters were 0.04, 0.2, and 0.15 mm, respectively, which were
not statistically different from zero (Figure 1
).
|
Assessment of Endothelial Function
Protocol
After at least 30 minutes of rest, arterial
endothelial and smooth muscle function was studied with
a high-resolution vascular ultrasound system as previously
described.3 The right brachial artery was studied in all
30 FH and 27 control subjects. Changes in arterial diameter
in response to reactive hyperemia (increased flow producing
endothelium-dependent vasodilation) and to
glyceryltrinitrate (GTN, an endothelium-independent
vasodilator) were measured. The subject rested in the supine position
for 10 minutes before the first scan and remained supine throughout the
study. The target artery was scanned in a longitudinal section (for the
brachial artery, 2 to 15 cm above the elbow), and the center of the
vessel was identified when the clearest images of the anterior and
posterior walls were obtained. The transmit zone was set to the level
of the anterior vessel wall. Depth and gain settings were optimized to
identify the lumen to vessel wall. Images were magnified with the
resolution box function, leading to a television line width of
0.065 mm. Machine settings were kept constant during each
study. Arterial flow velocity was measured by mean of a
pulsed-Doppler signal at a 60° angle to the vessel, with the
range gate (1.5 mm) in the center of the artery. Flow increase was
induced by inflation of a blood pressure cuff to 300 mm Hg. The
cuff was released after 4 minutes, and the artery was scanned for 30
seconds before and for 90 seconds after cuff deflation, including a
repeated flow velocity recording for 15 seconds after cuff
release. Ten minutes later, a resting scan was recorded. GTN
(400-µg spray) was then administered sublingually and the artery was
scanned after 3 minutes.
Phantom studies reported in the literature and performed in our laboratory have confirmed that changes in diameter of as little as 0.1 mm can be detected accurately with this method.2 There is a low coefficient of variation for measurements of arterial diameter (interobserver error) and a high correlation between consecutive control measurements within a study.22 23
Data Analysis
Arterial diameters were measured from S-VHS
videotape by 2 independent observers blinded to the scan sequence and
the identity of the subject by using the same analysis device
as for the CCA. Brachial diameters were measured from the anterior to
the posterior interface between the media and adventitia (the "m
line") at a fixed distance from an anatomic marker. The mean diameter
was calculated from 5 cardiac cycles incident with the R wave on the
electrocardiogram. For the hyperemia scan,
vessel diameter was measured 30 to 60 seconds after cuff release.
Diameter changes were derived as percentage changes relative to the
first scan. Baseline blood flow (measured during the first scan) was
estimated by multiplying angle-corrected, pulsed-Doppler
recordings of the flow velocity integral by heart rate and the
square of the radius of the artery. Reactive hyperemia was
calculated as the maximum flow measured during the first 15 seconds
after cuff deflation divided by the baseline flow.
Statistical Analysis
Descriptive data are expressed as mean±SD. Comparison between
groups was performed by 1-way ANOVA. Multivariable analysis
was used to study the relationship between the
Einc and age, mean blood pressure, and
total cholesterol. The linear relationship between LDL
cholesterol and the mechanical parameters of
the CCA was studied by multivariate analysis.
Statistical significance was considered for P<0.05.
| Results |
|---|
|
|
|---|
|
|
CCA Measurements
Table 3
reports anatomic and
mechanical parameters of the CCA. WCSA was
slightly (6%) but not significantly larger in FH than in controls
(P=0.1). Systolic and diastolic carotid
lumen diameters and IMT were not significantly different in the 2
groups. However, the systodiastolic changes in carotid
diameter (
D) were significantly lower in FH than in
controls (by 20%, P=0.0003). CCA CSC and
CSD values were significantly lower in the FH group (by 15%
and 19%, respectively; P=0.02 and P=0.004). In
parallel, the wall stiffness evaluated by
Einc was larger in FH subjects than in
controls (by 27%, P=0.003).
|
Brachial Artery Endothelial Function
There was no significant difference in resting diameters of the
right brachial artery in control and FH subjects (3.0±0.4 versus
3.0±0.5 mm, respectively). The hyperemic response in the
brachial artery, estimated as the maximal blood flow velocity
(cm3/s), was similar in FH and control subjects
(143±25% versus 139±18%, NS). GTN induced
(endothelium-independent) dilation of the brachial
artery was similar in both groups (maximal diameter, 3.7±0.6 versus
3.6±0.4 mm in control and FH, respectively; NS). However, the
flow-mediated dilation of the brachial artery (ie, dilation during the
reactive hyperemic response given in percent values of the
control diameter) was significantly impaired in the FH subjects
(flow-mediated dilation of 9.0±3.1% versus 4.2±2.9%,
P<0.001).
We did not find any correlation between
Einc and IMT or plasma total or LDL
cholesterol levels (Figure 2
). In contrast, the flow-mediated
dilation of the brachial artery was negatively correlated with the
plasma LDL cholesterol level (r= -0.40,
P=0.04; Figure 3
).
|
|
| Discussion |
|---|
|
|
|---|
Structural changes of the CCA wall occur very early in atherosclerosis.25 27 Therefore, they might be responsible for changes in arterial stiffness. However, in the present study, we did not find evidence of any echographic atherosclerotic lesions. Furthermore, the young age of our FH subjects is not very compatible with an advanced sclerosis of the arterial wall.
Foam cells are likely to be present in early CCA alterations and are known to be mainly composed of soft material. Thus, it is difficult to attribute the arterial stiffening to accumulation of foam cells in the arterial wall. Owing to the coexistence of atherosis and sclerosis, the latter is likely more involved in the alteration of arterial mechanical properties. This concept is supported by the absence of a correlation between CCA stiffness and plasma cholesterol and by the absence of a difference in wall thickness and mechanical characteristics of the CCA (compliance, distensibility, and Einc) between treated and untreated subjects. However, the small number of treated subjects in the present study makes interpretation of this result difficult. Furthermore, the narrow range of LDL values could also statistically remove a correlation between the mechanical properties of the CCA and the plasma LDL concentration even if the overall relationship were strong. Alternatively, CCA stiffness may be related to LDL level but is cumulative over long periods of time and is not related to the current LDL level measured on the day that the echographic measurements were made. Additionally, we report herein apparently paradoxical higher values of LDL and total cholesterol in treated than in untreated subjects. This is likely due to the need for treatment of FH children with higher plasma lipid anomalies, whereas subjects with abnormal but lower cholesterol levels did not receive such treatment.
The endothelium, source of multiple vasoactive factors,
is 1 of the major determinants of smooth muscle tone and thus, of the
mechanical properties of the arterial wall.
Endothelial function has been reported to be altered in
children with FH.2 3 4 Our present results are in
agreement with previous studies: the flow-mediated dilation of the
brachial artery was significantly decreased in FH subjects.
Furthermore, the value of flow-mediated dilation was significantly
smaller for higher values of LDL cholesterol in FH subjects
(Figure 3
), suggesting a link between LDL and impairment of the
endothelium-dependent, flow-mediated dilation.
In animal models, we have shown that an intact endothelium is required in vivo to achieve an adequate relationship between pulse pressure and diameter.28 Furthermore, NO donors are known to substantially alter the elasticity of large vessels, and their blockade in turn might favor arterial rigidity.24 The endothelium controls both smooth muscle tone and vascular wall remodeling. The mechanisms by which the endothelium controls vascular remodeling are not known, although several vasoactive molecules and growth factors have been implicated. NO produced by the endothelium is a likely candidate able to mediate vessel remodeling. Mechanical forces elicited by blood flow (shear stress) cause the acute release of NO and, after prolonged activation, induce endothelial NO synthase (eNOS) gene expression both in vitro and in vivo.29 30 NO is a potent vasodilator that inhibits extracellular matrix turnover31 and thus, could modify the mechanical properties of the arterial wall. In a high-flow rabbit model, we reported that pharmacological inhibition of NO release reduced the flow-dependent increase in carotid arterial diameter.32 In the same way, Rudic et al33 showed that in mice with targeted disruption of eNOS, the CCA did not remodel when subjected to a chronic increase in blood flow. In our present study, altered endothelium-dependent dilation observed in FH patients could be a consequence of altered eNOS function, which itself is responsible for alterations in arterial wall structure. The similar brachial artery diameter under rest (basal) conditions in both control subjects and hypercholesterolemic patients suggests that the endothelial dysfunction had no influence on the development of the brachial artery. However, markedly increased stiffness of the CCA could be due to altered extracellular matrix in FH patients.
In conclusion, we report that in children with FH, the CCA wall was stiffer than in control subjects matched for age and blood pressure. The stiffening of the CCA wall was not directly related to the plasma level of LDL or total cholesterol in FH children. Alterations in endothelial function and specifically, in flow-mediated arterial dilation, could account for altered vasomotor tone and/or arterial wall structure and therefore for properties of the large arteries.
Received November 12, 1999; accepted March 28, 2000.
| References |
|---|
|
|
|---|
2. Sorensen KE, Celermajer DS, Georgapoulos D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolaemia and is related to the Lp (a) level. J Clin Invest. 1994;93:5055.
3. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:11111115.[Medline] [Order article via Infotrieve]
4. Arcaro G, Zenere BM, Travia D, Zenti MG, Covi G, Lechi A, Muggeo M. Non-invasive detection of early endothelial dysfunction in hypercholesterlaemic subjects. Atherosclerosis. 1995;114:247254.[Medline] [Order article via Infotrieve]
5.
Yokoyama M, Henry PD. Sensitization of isolated canine
coronary arteries to calcium ions after exposure to
cholesterol. Circ Res. 1979;45:479486.
6.
Galle J, Busse R, Bassenge E.
Hypercholesterolemia and
atherosclerosis change vascular reactivity in rabbits
by different mechanisms. Arterioscler Thromb. 1991;11:17121718.
7. Lefer AM, Sedar AW. Endothelial alterations in hypercholesterolemia and atherosclerosis. Pharmacol Res. 1991;23:112.[Medline] [Order article via Infotrieve]
8.
Tonstad S, Joakimsen O, Stenland-Bugge E, Leren TP,
Ose L, Rusell D, Bonaa KH. Risk factors related to carotid intima-media
thickness and plaque in children with familial
hypercholesterolemia and control subjects.
Arterioscler Thromb Vasc Biol. 1996;16:984991.
9. Lehmann ED, Watts GF, Fatemi-Langroubi B, Gosling RG. Aortic compliance in young patients with heterozygous familial hypercholesterolaemia. Clin Sci. 1992;83:717721.[Medline] [Order article via Infotrieve]
10. Boutouyrie P, Laurent S, Girerd X, Benetos A, Lacolley P, Abergel E, Safar M. Common carotid artery stiffness and pattern of left ventricular hypertrophy in hypertensive patients. Hypertension. 1995;25[pt 1]:651659.
11.
Benetos A, Laurent S, Hoeks AP, Boutouyrie P, Safar ME.
Arterial alterations with aging and high blood pressure: a
noninvasive study of carotid and femoral artery. Arterioscler
Thromb. 1993;13:9097.
12. Ellefson RD, Caraway WT. Lipids and lipoproteins. In: Tietz NW, ed. Fundamentals of Clinical Chemistry. Philadelphia, Pa: WB Saunders; 1976.
13. Megnien JL, Simon A, Andriani A, Segond P, Jeannin S, Levenson J. Cholesterol lowering therapy inhibits the low-flow mediated vasoconstriction of the brachial artery in hypercholesterolaemic subjects. Br J Clin Pharmacol. 1996;42:187193.[Medline] [Order article via Infotrieve]
14.
The Expert Panel. Report of the National
Cholesterol Education Program Expert Panel on detection,
evaluation and treatment of the high blood cholesterol in
adults. Arch Intern Med. 1988;148:3669.
15.
Gariepy J, Massonneau M, Levenson J, Heudes D, Simon A.
Evidence for in vivo carotid and femoral wall thickening in human
hypertension: groupe de prévention cardio-vasculaire en
médecine du travail hypertension. Hypertension. 1993;22:111118.
16. Gariepy J, Simon A, Massonneau M, Linhart A, Levenson J. Wall thickening of carotid and femoral arteries in male subjects with isolated hypercholesterolemia: PCVMETRA Group. Atherosclerosis. 1995;113:141151.[Medline] [Order article via Infotrieve]
17. Girerd X, Acar CH, Mourad JJ, Boutouyrie P, Safar ME, Laurent S. Incompressibility of the human arterial wall: an in vitro ultrasound study. J Hypertens. 1992;10(suppl 6):S111S114.
18. Hoeks APG, Brands PJ, Smeets GAM, Reneman RS. Assessment of the distensibility of superficial arteries. Ultrasound Med Biol. 1990;16:121128.[Medline] [Order article via Infotrieve]
19.
Laurent S, Girerd X, Mourad JJ, Lacolley P, Beck L,
Boutouyrie P, Mignot JP, Safar M. Elastic modulus of the radial artery
wall material is not increased in patients with essential hypertension.
Arterioscler Thromb. 1994;14:12231233.
20. Bland JM, Altman DG. Statistical method for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307310.[Medline] [Order article via Infotrieve]
21. British Standards Institution. Precision of Test Method (BS5497, part1). London, UK: BSI; 1979.
22. Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population based ultrasonography study in eastern Finnish men. J Intern Med. 1991;229:225231.[Medline] [Order article via Infotrieve]
23. Levenson JA, Peronneau PP, Simon A, Safar ME. Pulsed Doppler: determination of diameter, blood flow velocity and volumic flow of brachial artery in man. Cardiovasc Res. 1981;15:164170.[Medline] [Order article via Infotrieve]
24. Nichols WW, ORourke MF. McDonalds Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 3rd ed. London, UK: E Arnold; 1990:77142, 216269, 283359, 398437.
25. Safar ME, Girerd X, Laurent S. Structural changes of large conduit arteries in hypertension. J Hypertens. 1995;14:545555.
26.
Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R.
Intimal plus medial thickness of the arterial wall: a
direct measurement with ultrasound imaging. Circulation. 1986;74:13991406.
27.
Blankenhorn DH, Kramsch DM. Reversal of atherosis and
sclerosis: the two components of atherosclerosis.
Circulation. 1989;79:17.
28.
Levy BI, Benessiano J, Poitevin P, Safar ME.
Endothelium-dependent mechanical properties of the
carotid artery in WKY and SHR: role of angiotensin
converting enzyme inhibition. Circ Res. 1990;66:321328.
29. Uematsu M, Ohara Y, Navas JP, Nishida K, Murphy TJ, Alexander RW, Nerem RM, Harrison DG. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol. 1995;269(6 pt 1):C1371C1388.
30.
Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH.
Chronic exercise in dogs increases coronary vascular nitric
oxide production and endothelial cell nitric
oxide synthase gene expression. Circ Res. 1994;74:349353.
31. Trachtman H, Futterweit S, Garg P, Reddy K, Singhal PC. Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. Biochem Biophys Res Commun. 1996;218:704708.[Medline] [Order article via Infotrieve]
32.
Tronc F, Wassef M, Esposito B, Henrion D, Glagov S,
Tedgui A. Role of NO in flow-induced remodeling of the rabbit common
carotid artery. Arterioscler Thromb Vasc Biol. 1996;16:12561262.
33. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest. 1998;101:731736.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
E. M. Urbina, R. V. Williams, B. S. Alpert, R. T. Collins, S. R. Daniels, L. Hayman, M. Jacobson, L. Mahoney, M. Mietus-Snyder, A. Rocchini, et al. Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents: Recommendations for Standard Assessment for Clinical Research: A Scientific Statement From the American Heart Association Hypertension, November 1, 2009; 54(5): 919 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kallio, E. Jokinen, M. Hamalainen, M. Saarinen, I. Volanen, T. Kaitosaari, J. Viikari, T. Ronnemaa, O. Simell, and O. T. Raitakari Decreased Aortic Elasticity in Healthy 11-Year-Old Children Exposed to Tobacco Smoke Pediatrics, February 1, 2009; 123(2): e267 - e273. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pahkala, O. J. Heinonen, H. Lagstrom, P. Hakala, O. Simell, J. S.A. Viikari, T. Ronnemaa, M. Hernelahti, L. Sillanmaki, and O. T. Raitakari Vascular Endothelial Function and Leisure-Time Physical Activity in Adolescents Circulation, December 2, 2008; 118(23): 2353 - 2359. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. van der Graaf, C. Cuffie-Jackson, M. N. Vissers, M. D. Trip, C. Gagne, G. Shi, E. Veltri, H. J. Avis, and J. J.P. Kastelein Efficacy and Safety of Coadministration of Ezetimibe and Simvastatin in Adolescents With Heterozygous Familial Hypercholesterolemia J. Am. Coll. Cardiol., October 21, 2008; 52(17): 1421 - 1429. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Martino, L. Loffredo, R. Carnevale, V. Sanguigni, E. Martino, E. Catasca, C. Zanoni, P. Pignatelli, and F. Violi Oxidative Stress Is Associated With Arterial Dysfunction and Enhanced Intima-Media Thickness in Children With Hypercholesterolemia: The Potential Role of Nicotinamide-Adenine Dinucleotide Phosphate Oxidase Pediatrics, September 1, 2008; 122(3): e648 - e655. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Stapleton, Adam. G. Goodwill, M. E. James, and J. C. Frisbee Altered mechanisms of endothelium-dependent dilation in skeletal muscle arterioles with genetic hypercholesterolemia Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1110 - R1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mariotti, J. F. Huneau, I. Szezepanski, K. J. Petzke, Y. Aggoun, D. Tome, and D. Bonnet Meal Amino Acids with Varied Levels of Arginine do Not Affect Postprandial Vascular Endothelial Function in Healthy Young Men J. Nutr., June 1, 2007; 137(6): 1383 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. McCrindle, E. M. Urbina, B. A. Dennison, M. S. Jacobson, J. Steinberger, A. P. Rocchini, L. L. Hayman, and S. R. Daniels Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing Circulation, April 10, 2007; 115(14): 1948 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-E. W. Kavey, V. Allada, S. R. Daniels, L. L. Hayman, B. W. McCrindle, J. W. Newburger, R. S. Parekh, and J. Steinberger Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics Circulation, December 12, 2006; 114(24): 2710 - 2738. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Laurent, J. Cockcroft, L. Van Bortel, P. Boutouyrie, C. Giannattasio, D. Hayoz, B. Pannier, C. Vlachopoulos, I. Wilkinson, H. Struijker-Boudier, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications Eur. Heart J., November 1, 2006; 27(21): 2588 - 2605. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Pena, E. Wiltshire, K. MacKenzie, R. Gent, L. Piotto, C. Hirte, and J. Couper Vascular Endothelial and Smooth Muscle Function Relates to Body Mass Index and Glucose in Obese and Nonobese Children J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4467 - 4471. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Groner, M. Joshi, and J. A. Bauer Pediatric Precursors of Adult Cardiovascular Disease: Noninvasive Assessment of Early Vascular Changes in Children and Adolescents Pediatrics, October 1, 2006; 118(4): 1683 - 1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Covic, N. Mardare, P. Gusbeth-Tatomir, O. Brumaru, C. Gavrilovici, M. Munteanu, O. Prisada, and D. J. A. Goldsmith Increased arterial stiffness in children on haemodialysis Nephrol. Dial. Transplant., March 1, 2006; 21(3): 729 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Juonala, M. J. Jarvisalo, N. Maki-Torkko, M. Kahonen, J. S.A. Viikari, and O. T. Raitakari Risk Factors Identified in Childhood and Decreased Carotid Artery Elasticity in Adulthood: The Cardiovascular Risk in Young Finns Study Circulation, September 6, 2005; 112(10): 1486 - 1493. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Ladeia, C. Ladeia-Frota, L. Pinho, E. Stefanelli, and L. Adan Endothelial Dysfunction Is Correlated With Microalbuminuria in Children With Short-Duration Type 1 Diabetes Diabetes Care, August 1, 2005; 28(8): 2048 - 2050. [Full Text] [PDF] |
||||
![]() |
G. Poelzl, M. Frick, H. Huegel, B. Lackner, H. F. Alber, J. Mair, M. Herold, S. Schwarzacher, O. Pachinger, and F. Weidinger Chronic heart failure is associated with vascular remodeling of the brachial artery Eur J Heart Fail, January 1, 2005; 7(1): 43 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Boreham, I. Ferreira, J. W. Twisk, A. M. Gallagher, M. J. Savage, and L. J. Murray Cardiorespiratory Fitness, Physical Activity, and Arterial Stiffness: The Northern Ireland Young Hearts Project Hypertension, November 1, 2004; 44(5): 721 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iannuzzi, M. R. Licenziati, C. Acampora, V. Salvatore, L. Auriemma, M. L. Romano, S. Panico, P. Rubba, and M. Trevisan Increased Carotid Intima-Media Thickness and Stiffness in Obese Children Diabetes Care, October 1, 2004; 27(10): 2506 - 2508. [Full Text] [PDF] |
||||
![]() |
C. M. Hutter, M. A. Austin, and S. E. Humphries Familial Hypercholesterolemia, Peripheral Arterial Disease, and Stroke: A HuGE Minireview Am. J. Epidemiol., September 1, 2004; 160(5): 430 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Slyper What Vascular Ultrasound Testing Has Revealed about Pediatric Atherogenesis, and a Potential Clinical Role for Ultrasound in Pediatric Risk Assessment J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3089 - 3095. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Oliver and D. J. Webb Noninvasive Assessment of Arterial Stiffness and Risk of Atherosclerotic Events Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 554 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Frick, S. P. Schwarzacher, H. F. Alber, A. Rinner, H. Ulmer, O. Pachinger, and F. Weidinger Morphologic rather than functional or mechanical sonographic parameters of the brachial artery are related to angiographically evident coronary atherosclerosis J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1825 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Kiefer, J. B. McKenney, J. F. Trainor, and L. M. Snyder Maturation-Dependent Acquired Coronary Structural Alterations and Atherogenesis in the Dahl Sodium-Sensitive Hypertensive Rat Circulation, November 5, 2002; 106(19): 2486 - 2490. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sorof and S. Daniels Obesity Hypertension in Children: A Problem of Epidemic Proportions Hypertension, October 1, 2002; 40(4): 441 - 447. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |